NINLARO (Ixazomib) Approved For Patients With Multiple Myeloma, Available At Biologics, Inc. (NC)

CARY, N.C.--(BUSINESS WIRE)--Biologics, Inc., is pleased to announce that it has been selected by Takeda Oncology as a specialty pharmacy provider for Ninlaro (ixazomib). Ninlaro was granted priority review and orphan drug status, and approved by the U.S. Food and Drug Administration on November 20, 2015, in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.

Biologics’ Oncology Pharmacy Services are designed to support patients needing complex oral, intravenous and self-injectable oncology therapies that require advanced clinical oncology support and prompt resolution of financial barriers.

Recognized for its high-touch patient care model, Biologics’ Oncology Pharmacy and Patient Access Services group provides a dedicated, clinically relevant team to support the clinical, financial and emotional needs of specific patient populations.

Care plans are developed according to each individual patient profile. According to the latest independent survey, 96% of patients reported having an exceptional overall experience with Biologics.

About Biologics: Biologics, Inc. is an oncology services company that empowers healthcare providers, payors and biopharma to optimize cancer care for the best possible outcomes – clinical, financial and emotional. Unifying fragmented healthcare services, Biologics brings efficiency and humanity to oncology care management by focusing on the patient’s best interest as the surest path to managing cost and risk. Biologics is at the center of a rapidly changing oncology environment and supports patients across all treatment modalities, while providing clinical outcomes and informatics reporting that allow for informed decision making. Since it was founded in 1994, Biologics has been dedicated to improving the lives of those fighting cancer. Privately held, Biologics maintains headquarters and operations in Cary, North Carolina. Visit biologicsinc.com or follow us on Twitter (@BiologicsInc).